Liu Y et al. |
Lyophilized Powder of Catalpol and Puerarin Protected Cerebral Vessels from Ischemia by Its Anti-apoptosis on Endothelial Cells. |
2017 |
Int. J. Biol. Sci. |
pmid:28367097
|
Ma X et al. |
Puerarin attenuates cisplatin-induced rat nephrotoxicity: The involvement of TLR4/NF-κB signaling pathway. |
2017 |
PLoS ONE |
pmid:28182789
|
Bacanlı M et al. |
The antioxidant, cytotoxic, and antigenotoxic effects of galangin, puerarin, and ursolic acid in mammalian cells. |
2017 |
Drug Chem Toxicol |
pmid:27461151
|
Wu L et al. |
Protective Effects of Puerarin against Aβ 1-42-Induced Learning and Memory Impairments in Mice. |
2017 |
Planta Med. |
pmid:27420352
|
KopeÄná-Zapletalová M et al. |
Interaction of isoflavonoids with human liver microsomal cytochromes P450: inhibition of CYP enzyme activities. |
2017 |
Xenobiotica |
pmid:27312150
|
Dong Z et al. |
RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model. |
2017 |
Biomed. Pharmacother. |
pmid:28236703
|
Li CH et al. |
Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages. |
2017 |
Eur. J. Pharmacol. |
pmid:28576406
|
Kim Y et al. |
Pharmacokinetics and Safety of DW1029M, a Botanical Drug for the Treatment of Diabetic Nephropathy, Following Single Doses in Healthy Subjects. |
2017 |
Clin Pharmacol Drug Dev |
pmid:28301092
|
Li P et al. |
In Vivo Pharmacokinetics of Puerarin via Different Drug Administration Routes Based on Middle Cerebral Artery Occlusion Model. |
2017 |
Eur J Drug Metab Pharmacokinet |
pmid:27928655
|
Wang L et al. |
Puerarin Enhances Ca2+ Reuptake and Ca2+ Content of Sarcoplasmic Reticulum in Murine Embryonic Stem Cell-Derived Cardiomyocytes via Upregulation of SERCA2a. |
2017 |
Cell. Physiol. Biochem. |
pmid:29179218
|
Wang J et al. |
Novel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies. |
2017 |
Int J Nanomedicine |
pmid:29158673
|
Lin L et al. |
The Effects and Possible Mechanisms of Puerarin to Treat Uterine Fibrosis Induced by Ischemia-Reperfusion Injury in Rats. |
2017 |
Med. Sci. Monit. |
pmid:28704345
|
Kong H et al. |
Pharmacokinetics and Tissue Distribution Kinetics of Puerarin in Rats Using Indirect Competitive ELISA. |
2017 |
Molecules |
pmid:28587251
|
Liu X et al. |
Puerarin suppresses LPS-induced breast cancer cell migration, invasion and adhesion by blockage NF-κB and Erk pathway. |
2017 |
Biomed. Pharmacother. |
pmid:28558356
|
Tang H et al. |
Puerarin attenuates myocardial hypoxia/reoxygenation injury by inhibiting autophagy via the Akt signaling pathway. |
2017 |
Mol Med Rep |
pmid:28393209
|
Shang Z et al. |
Rapid profiling and identification of puerarin metabolites in rat urine and plasma after oral administration by UHPLC-LTQ-Orbitrap mass spectrometer. |
2017 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:29073480
|
Deng HF et al. |
Puerarin inhibits expression of tissue factor induced by oxidative low-density lipoprotein through activating the PI3K/Akt/eNOS pathway and inhibiting activation of ERK1/2 and NF-κB. |
2017 |
Life Sci. |
pmid:29037842
|
Tan C et al. |
Puerarin Improves Vascular Insulin Resistance and Cardiovascular Remodeling in Salt-Sensitive Hypertension. |
2017 |
Am. J. Chin. Med. |
pmid:28830209
|
Zhang WG et al. |
Puerarin Induces Hepatocellular Carcinoma Cell Apoptosis Modulated by MAPK Signaling Pathways in a Dose-dependent Manner. |
2017 |
Anticancer Res. |
pmid:28739736
|
Wang K et al. |
Puerarin inhibits amyloid β-induced NLRP3 inflammasome activation in retinal pigment epithelial cells via suppressing ROS-dependent oxidative and endoplasmic reticulum stresses. |
2017 |
Exp. Cell Res. |
pmid:28583762
|